Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)
Niki BioSolutions announced that its subsidiary, DiamiR Biosciences, has entered into a strategic agreement to provide APOE genotyping services to Progressive Medical Research (PMR). The partnership leverages Niki's CAP and CLEP-approved testing platform to support PMR's clinical and translational research programs in Alzheimer's disease and cardiovascular health.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.